| Literature DB >> 30868735 |
Laura Carrera-García1,2, Daniel Natera-de Benito1,2, Klaus Dieterich3, Marta G G de la Banda4, Adrien Felter5, Emili Inarejos6, Anna Codina1,2, Cristina Jou1,2,7, Monica Roldan8, Francesc Palau9,10,11,12, Janet Hoenicka10,13, Jordi Pijuan10, Carlos Ortez1,2, Jessica Expósito-Escudero1,2, Chantal Durand14, Frédérique Nugues14, Cecilia Jimenez-Mallebrera1,2, Jaume Colomer1,2, Robert Y Carlier5, Hanns Lochmüller15,16,17, Susana Quijano-Roy4, Andres Nascimento1,2.
Abstract
Mutations in the CHRNG gene cause autosomal recessive multiple pterygium syndrome (MPS). Herein we present a long-term follow-up of seven patients with CHRNG-related nonlethal MPS and we compare them with the 57 previously published patients. The objective is defining not only the clinical, histopathological, and molecular genetic characteristics, but also the type and degree of muscle involvement on whole-body magnetic resonance imaging (WBMRI). CHRNG mutations lead to a distinctive phenotype characterized by multiple congenital contractures, pterygium, and facial dysmorphism, with a stable clinical course over the years. Postnatal abnormalities at the neuromuscular junction were observed in the muscle biopsy of these patients. WBMRI showed distinctive features different from other arthrogryposis multiple congenita. A marked muscle bulk reduction is the predominant finding, mostly affecting the spinal erector muscles and gluteus maximus. Fatty infiltration was only observed in deep paravertebral muscles and distal lower limbs. Mutations in CHRNG are mainly located at the extracellular domain of the protein. Our study contributes to further define the phenotypic spectrum of CHRNG-related nonlethal MPS, including muscle imaging features, which may be useful in distinguishing it from other diffuse arthrogryposis entities.Entities:
Keywords: zzm321990CHRNG; Escobar syndrome; arthrogryposis; multiple pterygium syndrome; whole-body MRI
Mesh:
Substances:
Year: 2019 PMID: 30868735 DOI: 10.1002/ajmg.a.61122
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802